Table 2.
Expression levels of 12 plasma miRNAs between early-stage NSCLC patients and healthy controls
| miRNAs | Expression | NSCLC/Healthy | P value |
|---|---|---|---|
| miR-20a | ↑ | 12.34 ± 0.78 | 1.45 × 10 −3 |
| miR-223 | ↑ | 5.67 ± 0.56 | 2.34 × 10 −3 |
| miR-21 | ↑ | 5.09 ± 0.53 | 3.31 × 10 −5 |
| miR-155 | ↑ | 4.34 ± 0.3 | 1.67 × 10 −3 |
| miR-221 | ↑ | 1.32 ± 0.29 | 0.063 |
| miR-25 | ↑ | 1.26 ± 0.28 | 0.082 |
| miR-182 | ↑ | 1.03 ± 0.27 | 0.723 |
| miR-30d | ↑ | 0.98 ± 0.25 | 0.459 |
| miR-126 | ↑ | 0.87 ± 0.24 | 0.239 |
| miR-320 | ↑ | 1.84 ± 0.77 | 0.071 |
| miR-210 | ↑ | 0.57 ± 0.15 | 0.563 |
| miR-145 | ↑ | 20.24 ± 0.83 | 3.56 × 10 −4 |